Another 8x Risk to Reward Stock (SBFM)
Aktualisiert
SBFM About
Sunshine Biopharma, Inc. is a New York-based pharmaceutical company that develops and commercializes oncology and antiviral drugs, as well as science-based nutritional supplements. Their products include treatments for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006.
Recent News
Stock Split April 17th, 2024
5 Point Inspection by OnePunchman:
- Free Float shares: 953.39 K - Positive
- Cash & equivalents: 16.29 M - Positive
- Debt: 657.71 K - Positive
- Last Quarter Revenue:7.68M - Positive compared to Cash in hand and Free Float
- Prescriptions Drugs are in the market - https://sunshinebiopharma.com/prescription-drugs/
Buy Alert done by Fibonacci retracement levels:
Price: $3.20
- Entire Position Stop Loss: $2.91
- 1st Take Profit: $5.30 (I would sell 50% of my holdings here) - Risk to Reward Ratio is x8
- 2nd Take Profit: $8.79 (I would sell 30% of my holdings here) - Risk to Reward Ratio is x21
- 3rd Take Profit: $10.25 (I would sell 20% of my remaining holdings here) - Risk to Reward Ratio is x27
Trade geschlossen: Stop wurde erreicht
Please subscribe to the channel at youtube.com/c/onepunchalgo to receive alerts via short videos for daily US stock trades.
Till we reach 1000 subscribers, we will post 1 stock per week after that we will post 1 stock every day.
Till we reach 1000 subscribers, we will post 1 stock per week after that we will post 1 stock every day.
Haftungsausschluss
Die Informationen und Veröffentlichungen sind nicht als Finanz-, Anlage-, Handels- oder andere Arten von Ratschlägen oder Empfehlungen gedacht, die von TradingView bereitgestellt oder gebilligt werden, und stellen diese nicht dar. Lesen Sie mehr in den Nutzungsbedingungen.